Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Gangneung
Clinical trial register · South Korea

Clinical Trials in Gangneung, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 2821 Daegu 554 Seongnam-si 493 Busan 468 Goyang-si 396
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Seung-Jung Park5 Seung-Whan Lee, M.D., Ph.D.3 Duk-Woo Park, MD3 Samsung Medical Center2 Jung-min Ahn2
Site location
Seoul2821 Daegu554 Seongnam-si493 Busan468 Goyang-si396
All 252 locations
Target enrolment
to

Trials with a site in Gangneung

26 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
Seoul National University Hospital
Not applicable
2,301
Chuncheon, Gangneung, Anyang-si, Bucheon-si, Goyang-si, Changwon, Busan, Daegu
2026-06-15
Recruiting
The DECISION-CTO Extended 10 Y Follow-up
NCT06908499Coronary Artery Disease
Seung-Jung Park
Observational
840
Anyang, Bucheon-si, Busan, Chuncheon, Daegu, Daejeon, Gangneung, Gwangju
2026-04-01
Recruiting
Seoul National University Bundang Hospital
Phase 2
130
Busan, Daegu, Gangneung, Seongnam-si, Incheon, Hwasun, Cheongju-si, Seoul
2025-08-27
By invitation
Effect of Daily Chlorhexidine Bathing and Antibiotic/PPI Stewardship on Prevention of CPE Transmission and Infection
NCT07039955Carbapenemase-Producing Enterobacteriaceae (CPE), Healthcare-Associated Infections (HAIs)
Chuncheon Sacred Heart Hospital
Not applicable
5,760
Chuncheon, Gangneung, Wŏnju
2025-07-14
Recruiting
Samsung Medical Center
Not applicable
1,200
Ansan, Daegu, Gangneung, Goyang, Gwangju, Gwangmyeong, Incheon, Jeonju
2025-04-07
Recruiting
Seoul National University Hospital
Phase 2
100
Gangneung, Anyang-si, Ilsan, Seongnam-si, Seoul
2025-03-11
Recruiting
Duk-Woo Park, MD
Phase 4
1,040
Bucheon-si, Changwon, Daegu, Daejeon, Gangneung, Gwangju, Ilsan, Incheon
2024-12-18
Recruiting
Duk-Woo Park, MD
Not applicable
1,500
Bucheon-si, Daegu, Daejeon, Gangneung, Gwangju, Ilsan, Incheon, Pusan
2024-06-14
By invitation
Seung-Whan Lee, M.D., Ph.D.
Phase 4
4,000
Bucheon-si, Changwon, Cheonju, Chuncheon, Daegu, Daejeon, Gangneung, Gwangju
2023-03-14
Recruiting
Seung-Whan Lee, M.D., Ph.D.
Not applicable
2,400
Anyang, Bucheon-si, Busan, Changwon, Cheongju-si, Daegu, Gangneung, Iksan
2023-03-13
Recruiting
Asan Medical Center
Phase 4
3,944
Bucheon-si, Busan, Changwon, Chuncheon, Chungju, Daegu, Daejeon, Gangneung
2022-10-21
Recruiting
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
NCT05044273Coronary Artery Disease, Cardiovascular Diseases, Heart Diseases, Myocardial Ischemia
Jung-min Ahn
Observational
2,000
Anyang, Busan, Changwon, Daegu, Gangneung, Gwangju, Iksan, Seongnam
2022-09-01
Active, closed
Drug-Coated Balloon in Patients With High Bleeding Risk
NCT05221931Coronary Artery Disease
Samsung Medical Center
Not applicable
1,359
Ansan, Cheongju-si, Daegu, Gangneung, Gwangju, Gwangmyeong, Incheon, Jinju
2022-07-29
Recruiting
Joon Bum Kim
Phase 4
1,300
Bucheon-si, Busan, Daegu, Gangneung, Gwangju, Seongnam, Seoul, Suwon
2022-02-21
Recruiting
Duk-Woo Park, MD
Observational
2,000
Chuncheon, Daegu, Daejeon, Gangneung, Kwangju, Pusan, Seoul, Suncheon
2020-09-17
Recruiting
Asan Medical Center
Observational
3,000
Bucheon-si, Busan, Changwon, Chuncheon, Daegu, Daejeon, Gangneung, Jeonju
2020-02-20
Active, closed
Timing of FFR-guided PCI for Non-IRA in STEMI and MVD (OPTION-STEMI)
NCT04626882Myocardial Infarction, Acute, Multi-Vessel Coronary Artery Stenosis
Chonnam National University Hospital
Not applicable
994
Bucheon-si, Changwon, Daegu, Gangneung, Gwangju, Jeonju, Jinju, Seoul
2019-12-30
Active, closed
Seung-Jung Park
Observational
2,000
Busan, Chuncheon, Daegu, Gangneung, Seoul, Suncheon, Wŏnju
2019-12-23
Recruiting
Seung-Whan Lee, M.D., Ph.D.
Observational
4,000
Anyang, Bucheon-si, Changwon, Cheongju-si, Chuncheon, Daegu, Daejeon, Gangneung
2018-01-11
Recruiting
Kee-joon Choi
Phase 4
140
Bucheon-si, Busan, Cheonan, Daegu, Daejeon, Gangneung, Gwangju, Iksan
2016-11-29
Active, closed
IRIS-Synergy Cohort in the IRIS-DES Registry
NCT02720419Coronary Artery Disease
Jung-min Ahn
Observational
3,000
Bucheon-si, Busan, Cheonan, Chuncheon, Daegu, Daejeon, Gangneung, Gwangju
2016-08
Active, closed
IRIS-Onyx Cohort in the IRIS-DES Registry
NCT02593994Coronary Artery Disease, Arterial Occlusive Diseases, Cardiovascular Diseases, Percutaneous Transluminal Angioplasty
Seung-Jung Park
Observational
4,500
Seoul, Anyang, Bucheon-si, Cheonan, Chuncheon, Daegu, Daejeon, Gangneung
2015-10
Recruiting
Gangwon PCI Prospective Registry
NCT02038127Coronary Artery Disease, Ischemic Heart Disease (IHD), Unstable Angina (UA), Non-ST Elevated Myocardial Infarction
Yonsei University
Observational
10,000
Chuncheon, Gangneung, Wŏnju
2013-01-01
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Yangsan, Busan, Changwon, Cheongju-si, Daegu, Daejeon, Gangneung, Gwangju
2012-01
Recruiting
Seung-Jung Park
Observational
20,000
Anyang, Bucheon-si, Cheongju-si, Chuncheon, Daegu, Daejeon, Gangneung, Gwangju
2011-06
Recruiting
Observational Study for Left Main Disease Treatment
NCT01341327Coronary Artery Disease
Seung-Jung Park
Observational
10,000
Anyang, Bucheon-si, Busan, Cheonan, Cheongju-si, Daegu, Daejeon, Gangneung
2007-07
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/gangneung

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Gangneung.

How many clinical trials are recruiting in Gangneung?

18 of the 26 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 5 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gangneung), 26 studies
PhaseStudiesRecruitingShare
Observational12946.2%
Not applicable7326.9%
Phase 45419.2%
Phase 2227.7%

Most active sponsors

Lead sponsors with the most studies (Gangneung)
Lead sponsorStudiesRecruiting
Seung-Jung Park53
Duk-Woo Park, MD33
Seung-Whan Lee, M.D., Ph.D.32
Asan Medical Center22
Jung-min Ahn21
Samsung Medical Center21
Seoul National University Hospital21
Chonnam National University Hospital10
Chuncheon Sacred Heart Hospital10
Joon Bum Kim11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.